Fondaparinux
Top View
- Attachment: Extract from Clinical Evaluation: Nadroparin
- (NSTEMI) Acute Coronary Syndrome Including Unstable Angina and Non-Q Wave Myocardial Infarction
- Center for Drug Evaluation and Research
- Unfractionated Heparin, LMWH & Fondaparinux
- Anti-Platelet and Anti-Coagulant Prescriptions and Breast Cancer Recurrence: a Danish Nationwide Prospective Cohort Study
- Journal of Chromatography A, 1479 (2017) 121–128
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Fondaparinux (Arixtra )
- Oral Direct Thrombin Inhibitors Or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism (Review)
- Fondaparinux Sodium (Arixtra®) VHA Pharmacy Benefits Management Strategic Healthcare Group and Medical Advisory Panel
- Fondaparinux), Lovenox® (Enoxaparin), Fragmin® (Dalteparin
- Bridging Antithrombotic Agents
- Switching to and from Various Anticoagulants
- Arixtra (Fondaparinux) Policy Number: C9084-A
- ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
- Fondaparinux (Arixtra®)
- (UFH) SC LMWH Or Fondaparinux Rivaroxaban
- Product Information for Fondaparinux